Epidemiology of sporotrichosis in Venezuela

International Journal of Dermatology

Volumn 52, Issue 8, 2013, Pages 974-980

  Mata Essayag, Sofia ^a   Delgado, Alejandro ^a   Colella, Maria T ^a   Landaeta Nezer, Maria E ^a   Rosello, Arantza ^a   Perez de Salazar, Celina ^a   Olaizola, Carolina ^a   Hartung, Claudia ^a   Magaldi, Sylvia ^a   Velasquez, Etna ^a  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE; POTASSIUM IODIDE;

ADOLESCENT; ADULT; ANTIMICROBIAL THERAPY; ARTICLE; CLINICAL FEATURE; DRUG CHOICE; DRUG EFFICACY; FEMALE; FOLLOW UP; FUNGUS TRANSMISSION; GROUPS BY AGE; HUMAN; MALE; MICROSCOPY; SPOROTRICHOSIS; VENEZUELA;

ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; SKIN DISEASES; SPOROTHRIX; SPOROTRICHOSIS; VENEZUELA; YOUNG ADULT;

EID: 84880696741     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2012.05849.x     Document Type: Article

References (59)

1. Rippon JW. Sporotrichosis. In: Rippon JW, eds. Medical Mycology. The Pathogenic Fungi and Pathogenic Actinomycetes, 3rd edn. Philadelphia, PA: WB Saunders, 1988: 325-352.
2. Kauffman CA. Sporotrichosis. State of the art clinical article. Clin Infect Dis 1999; 29: 231-236.
3. Lurie H. Sporotrichosis. In: Baker RD, eds. The Pathologic Anatomy of Mycoses. Human Infection with Fungi Actinomycetes and Algae. Berlin: Springer, 1971: 614-675.
4. Borelli D. Esporotricosis. Rev Ven Dermatol 1963; 4: 89- 105.
5. Conti-Díaz IA. Epidemiology of sporotrichosis in Latin America. Mycopathologia 1989; 108: 113-116.
6. Mackinnon JE, Conti-Díaz IA, Gezuele E, et al. Isolation of Sporothrix schenckii from nature and considerations on its pathogenicity and ecology. Sabouraudia 1969; 7: 38-45.
7. Dixon DM, Salkin IF, Duncan RA, et al. Isolation and characterization of Sporothrix schenckii from clinical and environmental sources associated with the largest U.S. epidemic of sporotrichosis. J Clin Microbiol 1991; 29: 1106-1113.
8. Lopes-Bezerra LM, Schubach A, Costa RO. Sporothrix schenckii and sporotrichosis. An Acad Bras Cienc 2006; 78: 293-308.
9. Macotela-Ruiz E, Nochebuena-Ramos E. Esporotricosis en algunas comunidades rurales de la Sierra Norte de Puebla. Informe de 55 casos (Septiembre 1995-Diciembre 2005). Gac Med Mex 2006; 142: 377-380.
10. Ramírez M, Andagua J, Lizárraga J, et al. Esporotricosis en pacientes que acuden a un centro médico de referencia en Abancay, Perú. Rev Peru Med Exp Salud Pública 2011; 28: 508-512.
11. Espinosa-Texis A, Hernández-Hernández F, Lavalle P, et al. Study of 50 patients with sporotrichosis. Clinical and laboratory assessment. Gac Med Mex 2001; 137: 111-116.
12. Schubach A, Barros MB, Wanke B. Epidemic sporotrichosis. Curr Opin Infect Dis 2008; 21: 129-133.
13. Pappas PG, Tellez I, Deep AE, et al. Sporotrichosis in Peru: description of an area of hyperendemicity. Clin Infect Dis 2000; 30: 65-70.
14. Kusuhara M, Hachisuka H, Sasai Y. Statistical survey of 150 cases with sporotrichosis. Mycopathologia 1988; 102: 129-133.
15. Mahajan VK, Sharma NL, Sharma RC, et al. Cutaneous sporotrichosis in Himachal Pradesh, India. Mycoses 2005; 48: 25-31.
16. Criseo G, Malara G, Romeo O, et al. Lymphocutaneous sporotrichosis in an immunocompetent patient: a case report from extreme Southern Italy. Mycopathologia 2008; 166: 159-162.
17. Rubio G, Sánchez G, Porras L, et al. Esporotrosis: prevalencia, perfil clínico y epidemiológico en un centro de referencia en Colombia. Rev Iberoam Micol 2010; 27: 75-79.
18. Gumaa SA. Sporotrichosis in Sudan. Trans R Soc Trop Med Hyg 1978; 72: 637-640.
19. Feeney KT, Arthur IH, Whittle AJ, et al. Outbreak of sporotrichosis, Western Australia. Emerg Infect Dis 2007; 13: 1228-1231.
20. Findlay GH. The epidemiology of sporotrichosis in the Transvaal. Sabouraudia 1970; 7: 231-236.
21. Conti-Diaz I. Sporotrichosis in Uruguay: epidemiologic and clinical aspects. In: Acuña H, eds. Proceedings of Fifth International Conference on the Mycoses. Superficial, Cutaneous, and Subcutaneous Infections. Washington, DC: Pan American Health Organization, 1980: 312-321.
22. Haddad V, Miot HA, Bartolli LD, et al. Localized lymphatic sporotrichosis alter fish-induced injury (Tilapia sp.). Med Micol 2002; 40: 425-427.
23. Bastardo de Albornoz MC. Esporotricosis. In: Albornoz MC. Boletín Informativo Las Micosis en Venezuela 1997; 30: 25-28.
24. Torres A, Boanerges Ramirez J, Tota M, et al. Un caso de esporotricosis. Boletín Informativo Las Micosis en Venezuela 1987; 7: 19.
25. Thompson DW, Kaplan W. Laboratory-acquired sporotrichosis. Sabouraudia 1977; 15: 167-170.
26. Albornoz-Bastardo MC. Esporotricosis. In: Albornoz MC, eds. Temas de Micología Médica. Caracas: ELALCA, 1996: 103-128.
27. Ruiz A, Cirocco A, Rodriguez H. Micosis Cutaneas profundas: estudio retrospectivo desde 1997 hasta el 2001 en la consulta de micologia del Servicio de Dermatologia del Hospital Universitario de Caracas. Dermatol Venez 2004; 42: 35-37.
28. Gómez H, González E. Reporte de un caso de lesión en mucosa causada por el Sporothrix schenckii. Boletín Informativo Las Micosis en Venezuela 1990; 16: 21.
29. Díaz J, de Sanabria A, Zerpa U, et al. Esporotricosis: reporte de 3 casos. Boletín Informativo Las Micosis en Venezuela 1994; 26: 15.
30. Padrón EA, Cermeño JR, Cabello I et al. Frecuencia de las micosis cutáneas, subcutáneas y profundas en el Complejo Universitario Ruiz y Páez. Ciudad Bolívar. Estado Bolívar 2005. In: Albornoz MC. Boletín Informativo Las Micosis en Venezuela 2007-2008; 40: 10-12.
31. Ramos de Díaz E. Esporotricosis. Boletín Informativo Las Micosis en Venezuela 1990; 18: 21-24.
32. Lizardo C, De Gregorio R, Borelli D. Esporotricosis en una niña de 27 meses. Rev Dermatol Venez 1960; 2: 242-244.
33. Quiñones AG, Alió AB, Aranzazu N, et al. Esporotricosis: presentación inusual. Dermatol Venez 1998; 36: 101-104.
34. Borelli D. Medios Caseros para Micología. Arch Venez Med Trop Parasitol Med 1962; IV: 302-310.
35. Barros MBL, Schubach TP, Coll JO, et al. Esporotricose: a evolução e os desafios de uma epidemia. Rev Panam Salud Publica 2010; 27: 455-460.
36. Mendoza M, Díaz E, Alvarado P, et al. Aislamiento de Sporothrix schenckii del medio ambiente en Venezuela. Rev Iberoam Micol 2007; 24: 317-319.
37. Novoa-Montero D, Serrano JA. Review on human mycoses in Venezuela. Rev Soc Ven Microbiol 2001; 21: 46-68.
38. Beer-Romero P, Rodríguez-Ochoa G, Angulo R, et al. Sporotrichosis in the Orinoco river basin of Venezuela and Colombia. Mycopathologia 1989; 105: 19-23.
39. Bonifaz A, Saúl A, Paredes-Solis V, et al. Sporotrichosis in childhood: clinical and therapeutic experience in 25 patients. Pediatr Dermatol 2007; 24: 369-372.
40. Aldama A, Correa J, Rivalli V, et al. Esporotricosis en niños: comunicación de tres casos con localización facial. Pediatr (Asunción) 2000; 27: 32-36.
41. Mariant F. Observations sur L'ecologie de Sporothrix schenckii et de Ceratocystis stenoceras en Corse et en Alsace, provinces francaises indemnes de sporotrichose. Sabouraudia 1975; 13: 217-225.
42. Falqueto A, Bravim Maifrede S, Araujo Ribeiro M. Unusual clinical presentation of sporotrichosis in three members of one family. Int J Dermatol 2012; 51: 434-438.
43. Londero AT, Ramos CD. Esporotricose. Estudo de 195 casos observados no Interior do Estado do Rio Grande do Sul. Rev AMRIGS Porto Alegre 1980; 24: 104-106.
44. Almeida HL Jr, Lettnin CB, Barbosa JL, et al. Spontaneous resolution of zoonotic sporotrichosis during pregnancy. Rev Inst Med Trop Sao Paulo 2009; 51: 237-238.
45. Koga T, Matsuda T, Matsumoto T, et al. Therapeutic approaches to subcutaneous mycoses. Am J Clin Dermatol 2003; 4: 537-543.
46. Arenas Guzmán R. Esporotricosis. In: Arenas Guzman R, eds. Micología Médica Ilustrada, 2nd edn. Mexico, DF: McGraw-Hill Interamericana, 2003: 129-137.
47. Lauermann F, Lyra M, Gaudio R. Sprotrichosis mimicking keratoacanthoma. Am J Trop Med Hyg 2012; 86: 741.
48. Freitas DFS, Hoagland BS, do Valle ACF, et al. Sporotrichosis in HIV-infected patients: report of 21 cases of endemic sporotrichosis in Rio de Janeiro, Brazil. Med Mycol 2012; 50: 170-178.
49. Takenaka M, Sato S, Nishimoto K. Survey of 155 sporotrichosis cases examined in Nagasaki prefecture from 1951 to 2007. Nippon Ishinkin Gakkai Zasshi 2009; 50: 101-108.
50. Gezuele E, Da Rosa D. Relevancia del cuerpo asteroide esporotricósico en el diagnóstico rápido de la esporotricosis. Rev Iberoam Micol 2005; 22: 147-150.
51. Da Rosa DW, Gezuele E, Calegari L, et al. Asteroid body in sporotrichosis. Yeast viability and biological significance within the host immune response. Med Mycol 2008; 46: 443-448.
52. Rodríguez G, Sarmiento L. The asteroid bodies of sporotrichosis. Am J Dermatopathol 1998; 20: 246-249.
53. Reyes H, Mata-Essayag S, Magaldi S, et al. Utilidad del método LA-Sporothrix Antibody System en el diagnóstico de la esporotricosis cutánea. Rev Soc Ven Microbiol 2003; 23: 163-165.
54. Kauffman CA, Bustamante B, Chapman SW, et al. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007; 45: 1255-1265.
55. Kauffman C. Old and new therapies for sporotrichosis. Clin Infect Dis 1995; 21: 981-985.
56. Bustamante B, Campos PE. Sporotrichosis: a forgotten disease in the drug research agenda. Expert Rev Anti-infect Ther 2004; 2: 85-94.
57. Xue S-L, Li L. Oral potassium iodide for the treatment of sporotrichosis. Mycopathologia 2009; 167: 355-356.
58. Hassan I, Keen A. Potassium iodide in dermatology. Indian J Dermatol Venereol Leprol 2012; 78: 390-393.
59. Venadero Albarrán F, Orellana Arauco A, Castillón Alcaraz S, et al. Esporotricosis Linfangítica. A propósito de diferentes alternativas de Tratamiento. Dermatol Rev Mex 2010; 54: 145-149.